Related Experiment Video
Updated: Apr 6, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Rheb signaling and tumorigenesis: mTORC1 and new horizons
Marisol E Armijo1, Tania Campos1, Francisco Fuentes-Villalobos1
1Laboratorio de Transducción de Señales y Cáncer, Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Biológicas, Universidad De Concepción, Concepción, Chile.
Abstract:
Rheb is a conserved small GTPase that belongs to the Ras superfamily, and is mainly involved in activation of cell growth through stimulation of mTORC1 activity. Because deregulation of the Rheb/mTORC1 signaling is associated with proliferative disorders and cancer, inhibition of mTORC1 has been therapeutically approached. Although this therapy has proven antitumor activity, its efficacy is not as expected. Here, we will review the main work on the identification of the role of Rheb in cell growth, and on the relevance of Rheb in proliferative disorders, including cancer. We will also review the Rheb functions that could explain tumor resistance to therapies with mTORC1 inhibitors, and will mainly focus our discussion on mTORC1-independent Rheb functions that could also be implicated in cancer cell survival and tumorigenesis. The current progress on the understanding of the noncanonical Rheb functions prompts future studies to establish their relevance in cancer and in the context of current cancer therapies.
Insights
The small GTPase Rheb regulates cell growth via mTORC1 signaling. Understanding Rheb
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Rheb, a Ras superfamily GTPase, is crucial for cell growth by activating mTORC1.
- Dysregulation of Rheb/mTORC1 signaling contributes to proliferative disorders and cancer.
- mTORC1 inhibitors show antitumor activity but face limitations in efficacy.
Purpose of the Study:
- To review Rheb's role in cell growth and its relevance in proliferative disorders and cancer.
- To explore Rheb functions contributing to resistance against mTORC1 inhibitors.
- To focus on mTORC1-independent Rheb functions in cancer cell survival and tumorigenesis.
Main Methods:
- Literature review of Rheb's role in cell growth.
- Analysis of Rheb's involvement in proliferative disorders and cancer.
- Examination of Rheb functions related to mTORC1 inhibitor resistance.
Main Results:
- Rheb's canonical role in stimulating mTORC1-mediated cell growth is established.
- Rheb deregulation is linked to various cancers.
- Noncanonical Rheb functions may drive cancer cell survival and tumor resistance.
Conclusions:
- Further research into Rheb's noncanonical functions is essential for understanding cancer.
- Targeting Rheb's diverse roles may overcome resistance to current cancer therapies.
- Understanding Rheb's multifaceted functions can inform novel therapeutic strategies for cancer.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
The Ras Gene
Ras is a...
MAPK Signaling Cascades
TGF - β Signaling Pathway

